The association of lipids and novel non-statin lipid-lowering drug target with osteoporosis: evidence from genetic correlations and Mendelian randomization
Abstract Background It remains controversial whether lipids affect osteoporosis (OP) or bone mineral density (BMD), and causality has not been established. This study aimed to investigate the genetic associations between lipids, novel non-statin lipid-lowering drug target genes, and OP and BMD. Meth...
Saved in:
Main Authors: | Qingcong Zheng, Rongjie Lin, Du Wang, Rongsheng Chen, Weihong Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12891-024-08160-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The diagnostic value of the combined application of blood lipid metabolism markers and interleukin-6 in osteoporosis and osteopenia
by: Liping Fan, et al.
Published: (2025-02-01) -
Associations between lipid-lowering drugs and urate and gout outcomes: a Mendelian randomization study
by: Min Liu, et al.
Published: (2025-01-01) -
Multidimensional Plasma Lipids Affect Preeclampsia/Eclampsia: A Mendelian Randomization Study
by: Shaole Shi, et al.
Published: (2025-01-01) -
Lipid-lowering drug targets and lung related diseases: a Mendelian randomization study
by: Haifeng Yu, et al.
Published: (2024-12-01) -
Genetic Insights Into Lipid Traits and Lipid-Modifying Drug Targets in Pregnancy Complications: A Two-Sample Mendelian Randomization Study
by: Shao H, et al.
Published: (2025-01-01)